Qiagen Pays $28.5M Cash For Molecular Staging Technology Sep. 29, 2004 By Cormac Sheridan No Comments Qiagen NV is paying $28.5 million in cash to acquire whole-genome amplification technology from Molecular Staging Inc. (BioWorld International)Read More
Active Biotech Seeking SEK150M In Convertible Debentures Issue Sep. 22, 2004 By Cormac Sheridan No Comments
Active Biotech Seeking SEK150M In Convertible Debentures Issue Sep. 22, 2004 By Cormac Sheridan No Comments
Karo Bio Seeking SEK96M, Cutting 20 R&D Employees Sep. 15, 2004 By Cormac Sheridan No Comments Karo Bio AB is laying off 20 staff members as part of an overall effort to re-orient the company toward clinical development. (BioWorld International)Read More
Karo Bio Seeking SEK96M, Cutting 20 R&D Employees Sep. 15, 2004 By Cormac Sheridan No Comments Karo Bio AB is laying off 20 staff members as part of an overall effort to re-orient the company toward clinical development. (BioWorld International)Read More
